SCHEMBL24656129

SCHEMBL24656129

CC(C)(C)c1ccc(C(F)(F)F)c(-n2cnnc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
KIF11 P52732 1/20 0.37
ALDH1A1 P00352 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
PKM P14618 2/20 0.35
AMY1A P0DUB6 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
PMP22 Q01453 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21849218 0.79 PKM (0.37) NOTUMKIF11ALDH1A1TDP1PKM
SCHEMBL21849213 0.77 PKM (0.38) ALDH1A1TDP1PKMAMY1AMEN1
SCHEMBL23589443 0.76 ALDH1A1 (0.52) ALDH1A1TDP1PKMAMY1AMEN1
SCHEMBL29935776 0.73 KIF11 (0.49) NOTUMCA12CA9KIF11ALDH1A1
SCHEMBL24656135 0.73 METAP2 (0.46) ALDH1A1KMT2A
SCHEMBL13171669 0.72 KIF11 (0.47) NOTUMKIF11ALDH1A1TDP1PKM
SCHEMBL31133447 0.71 TTR (0.49) NOTUMCA12CA9
SCHEMBL12391446 0.70 NOTUM (0.45) NOTUMKIF11ALDH1A1PKMLMNA
SCHEMBL12773796 0.70 PDE2A (0.49) KIF11ALDH1A1TDP1PKMMEN1
SCHEMBL12773797 0.70 KIF11 (0.46) KIF11ALDH1A1TDP1PKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP NOTUM 931/4885CA12 4341/4885CA9 4005/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP NOTUM 931/4885CA12 4341/4885CA9 4005/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP NOTUM 931/4885CA12 4341/4885CA9 4005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.